Health Care & Life Sciences » Pharmaceuticals | Granules India Ltd.

Granules India Ltd. | Cash Flow

Fiscal year is April-March. All values INR Millions.
2014
2015
2016
2017
2018
2019
Net Income before Extraordinaries
1,124
1,280
1,860
2,050
1,800
-
Depreciation, Depletion & Amortization
310
527
584
715
762
-
Other Funds
239
289
459
633
555
-
Funds from Operations
1,194
1,517
1,986
2,132
2,007
-
Changes in Working Capital
310
313
797
524
2,300
-
Net Operating Cash Flow
884
1,204
1,189
1,608
293
-
Capital Expenditures
2,667
1,481
1,622
3,166
4,464
Sale of Fixed Assets & Businesses
18
8
10
10
1
Purchase/Sale of Investments
95
-
-
-
-
Net Investing Cash Flow
2,556
1,475
1,664
3,291
4,650
Cash Dividends Paid - Total
47
83
234
223
290
Issuance/Reduction of Debt, Net
1,709
579
133
872
461
Net Financing Cash Flow
1,672
507
1,229
878
5,600
Net Change in Cash
-
236
754
805
657
Free Cash Flow
1,783
277
433
1,558
4,758
Net Assets from Acquisitions
-
-
52
134
187
Change in Capital Stock
11
11
1,330
829
2,930
Other Uses
1
2
-
-
-

About Granules India

View Profile
Address
2nd Floor, 3rd Block
Hyderabad TS 500081
India
Employees -
Website http://www.granulesindia.com
Updated 07/08/2019
Granules India Ltd. engages in the manufacturing and marketing of pharmaceutical products. It offers active pharmaceutical ingredients, pharmaceutical formulation intermediates, and finished dosages. The company was founded by Krishna Prasad Chigurupati on March 18, 1991 and is headquartered in Hyderabad, India.